ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselRocketvax AG
Rocketvax AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Rocketvax AG is a Swiss biotechnology company developing next-generation vaccines based on live-attenuated viruses. Its lead candidates, RVX-sCPD9 and RVX-OTS, are intended to protect against infection with existing and emerging SARS-CoV-2 variants.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Rocketvax AG

✓ Offered4
Development of live-attenuated vaccines
Development of next-generation vaccines based on live-attenuated virus technology for established and new indications, focused on infectious diseases and unmet medical needs.
Development of SARS-CoV-2 vaccine candidates
Development of SARS-CoV-2 vaccine candidates RVX-sCPD9 and RVX-OTS as well as OTS-228, with preclinical data on safety, efficacy, stability and transmission-blocking immunity.
Nasal vaccine development
Development of a needle-free intranasal vaccine candidate against SARS-CoV-2, focused on easy administration, local immunity, reduced transmission and broad variant coverage.
Vaccine platform technology
Rational genetic design and proprietary vaccine platform technology for generating attenuated viruses, described as applicable to coronaviruses, influenza, flaviviruses, pneumoviruses, alphaviruses and herpes.
Trust & reputation

ranQ Trust Score of Rocketvax AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Without public customer reviews the score stays capped.

Rocketvax AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Rocketvax AG scores 81.6 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Rocketvax AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Rocketvax AG scores 27.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.45.74%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

Rocketvax AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

March 18, 2022Media
Researchers accelerate two SARS-Cov-2 vaccine candidates into clinical trials
startupticker.ch

Knowledge

No knowledge articles yet

Once Rocketvax AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Rocketvax AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Rocketvax AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Rocketvax AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lautengartenstrasse 6
4052 Basel
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-204.298.880
Founded
2019 · 7 years
Last commercial register change
July 31, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MS
    Moderna Switzerland GmbH
    Basel
    CA
    CanVirex AG
    Basel
    AS
    Azafaros Switzerland AG
    Basel
    GG
    Galapagos GmbH
    Basel
    SA
    Seqirus AG
    Basel
    AM
    Altamira Medica AG
    Basel
    ST
    Skyhawk Therapeutics Europe GmbH
    Basel
    NA
    NOUSCOM AG
    Basel